Rivera Díaz, Raquel
Enfermedad renal y psoriasis. ¿Una nueva comorbilidad?. [artículo] - Actas dermo-sifiliográficas, 2016 - 107(10):823-29.
Formato Vancouver:
González Parra E, Daudén E, Carrascosa JM, Olveira A, Botella R, Bonanad C et al; en representación del Grupo de Trabajo en Inflamación Sistémica en Psoriasis. Kidney Disease and Psoriasis. A New Comorbidity? Actas Dermosifiliogr. 2016 Dec;107(10):823-29.
PMID: 27497509
Contiene 70 referencias
Psoriasis is a chronic inflammatory disease that has been associated with cardiovascular and metabolic comorbidities, particularly in young patients and patients with more severe forms of the disease. Recent studies have also linked psoriasis to kidney disease, and this would seem only logical, as the kidney is both a target of classic cardiovascular risk factors and susceptible to the toxic effects of some of the traditional drugs used to control psoriasis. In this article, we would like to draw readers' attention to this recently described comorbidity and stress the importance of early detection, as once chronic kidney disease develops, it cannot be reversed. When evaluating patients with psoriasis, particularly when they are candidates for systemic therapy, we believe it is important to order laboratory tests including glomerular filtration rate and a simple urine test to screen for albuminuria (albumin/creatinine ratio).
Enfermedad renal y psoriasis. ¿Una nueva comorbilidad?. [artículo] - Actas dermo-sifiliográficas, 2016 - 107(10):823-29.
Formato Vancouver:
González Parra E, Daudén E, Carrascosa JM, Olveira A, Botella R, Bonanad C et al; en representación del Grupo de Trabajo en Inflamación Sistémica en Psoriasis. Kidney Disease and Psoriasis. A New Comorbidity? Actas Dermosifiliogr. 2016 Dec;107(10):823-29.
PMID: 27497509
Contiene 70 referencias
Psoriasis is a chronic inflammatory disease that has been associated with cardiovascular and metabolic comorbidities, particularly in young patients and patients with more severe forms of the disease. Recent studies have also linked psoriasis to kidney disease, and this would seem only logical, as the kidney is both a target of classic cardiovascular risk factors and susceptible to the toxic effects of some of the traditional drugs used to control psoriasis. In this article, we would like to draw readers' attention to this recently described comorbidity and stress the importance of early detection, as once chronic kidney disease develops, it cannot be reversed. When evaluating patients with psoriasis, particularly when they are candidates for systemic therapy, we believe it is important to order laboratory tests including glomerular filtration rate and a simple urine test to screen for albuminuria (albumin/creatinine ratio).
